Nakyung Lee
Overview
Explore the profile of Nakyung Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bae S, Choi H, Lee J, Kang M, Ahn S, Lee Y, et al.
Small
. 2024 Sep;
21(8):e2405618.
PMID: 39264000
Since the coronavirus pandemic, mRNA vaccines have revolutionized the field of vaccinology. Lipid nanoparticles (LNPs) are proposed to enhance mRNA delivery efficiency; however, their design is suboptimal. Here, a rational...
2.
Chung H, Lee N, Lee H, Cho Y, Woo J
PLoS One
. 2023 Sep;
18(9):e0288432.
PMID: 37768896
Image search systems could be endangered by adversarial attacks and data perturbations. The image retrieval system can be compromised either by distorting the query or hacking the ranking system. However,...
3.
Kim D, Lee S, Park S, Kim P, Lee S, Lee N, et al.
Vaccines (Basel)
. 2022 Nov;
10(11).
PMID: 36366372
During the COVID-19 pandemic, vaccines were developed based on various platform technologies and were approved for emergency use. However, the comparative analysis of immunogenicity and durability of vaccine-induced antibody responses...
4.
Lee J, Park S, Kim J, Lim S, Chang E, Bae S, et al.
J Infect
. 2022 Oct;
85(6):e177-e180.
PMID: 36223860
No abstract available.
5.
Puray-Chavez M, Lee N, Tenneti K, Wang Y, Vuong H, Liu Y, et al.
mBio
. 2022 May;
13(3):e0081522.
PMID: 35604092
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) utilizes a number of strategies to modulate viral and host mRNA translation. Here, we used ribosome profiling in SARS-CoV-2-infected model cell lines and...
6.
Lim S, Jung J, Kim J, Park S, Kwon J, Park S, et al.
Clin Transl Med
. 2022 Apr;
12(4):e804.
PMID: 35452187
No abstract available.
7.
Lim S, Kim J, Park S, Kwon J, Park J, Cha H, et al.
Immune Netw
. 2022 Jan;
21(6):e41.
PMID: 35036028
Correlation between vaccine reactogenicity and immunogenicity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Thus, we investigated to determine whether the reactogenicity after coronavirus disease 2019 vaccination is...
8.
Kim J, Lim S, Park S, Kwon J, Bae S, Park J, et al.
J Infect Dis
. 2021 Dec;
225(5):777-784.
PMID: 34850034
Background: There are limited data directly comparing immune responses to vaccines and to natural infections with coronavirus disease 2019 (COVID-19). This study assessed the immunogenicity of the BNT162b2 and ChAdOx1...
9.
Kim J, Bae S, Park S, Kwon J, Lim S, Park J, et al.
Immune Netw
. 2021 Sep;
21(4):e29.
PMID: 34522442
There are limited data directly comparing humoral and T cell responses to the ChAdOx1 nCoV-19 and BNT162b2 vaccines. We compared Ab and T cell responses after first doses of ChAdOx1...
10.
Puray-Chavez M, LaPak K, Schrank T, Elliott J, Bhatt D, Agajanian M, et al.
Cell Rep
. 2021 Jul;
36(2):109364.
PMID: 34214467
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) variants govern transmissibility, responsiveness to vaccination, and disease severity. In a screen for new models of SARS-CoV-2 infection, we identify human...